Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Shareholding breakup across reporting periods.
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters + | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% | 62.70% |
| FIIs + | 0.68% | 0.43% | 0.39% | 0.07% | 0.00% | 0.00% | 0.03% | 0.02% | 0.00% | 0.00% | 0.00% | 0.01% |
| DIIs + | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% | 0.06% |
| Public + | 36.57% | 36.82% | 36.87% | 37.17% | 37.24% | 37.25% | 37.22% | 37.22% | 37.24% | 37.24% | 37.26% | 37.24% |
| No. of Shareholders | 15,267 | 15,119 | 14,629 | 13,740 | 13,602 | 13,426 | 13,475 | 13,139 | 12,060 | 11,843 | 11,715 | 10,567 |
Pros & Cons
Key positives and risks surfaced from the company insights section.
Financials of AksharChem (I)
Quarter-by-quarter operating performance
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 73 | 75 | 82 | 86 | 79 | 91 | 91 | 97 | 89 | 80 | 106 | 141 | 160 |
| Expenses + | 76 | 70 | 81 | 80 | 73 | 84 | 84 | 91 | 87 | 77 | 100 | 118 | 140 |
| Operating Profit | -3 | 5 | 0 | 6 | 6 | 6 | 6 | 6 | 2 | 3 | 5 | 23 | 21 |
| OPM % | -4.4% | 7% | 0.5% | 7% | 8% | 7% | 7% | 7% | 2.6% | 3.6% | 5% | 16% | 13% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 2 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Profit before tax | -8 | 1 | -4 | 2 | 1 | 2 | 1 | 1 | -1 | -3 | -1 | 16 | 14 |
| Tax % | 1% | 57% | 50% | 28% | 26% | 22% | -7% | 31% | -3% | 50% | -584% | 5% | 5% |
| Net Profit + | -8 | 0 | -6 | 1 | 1 | 1 | 1 | 1 | -1 | -5 | 5 | 15 | 13 |
| EPS in Rs | -9.46 | 0.41 | -7.49 | 1.43 | 1.29 | 1.48 | 1.73 | 0.88 | -1.71 | -5.75 | 6.03 | 18.93 | 16.58 |
Financials of AksharChem (I)
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 200 | 188 | 248 | 264 | 323 | 260 | 246 | 380 | 335 | 302 | 346 | 372 | 488 |
| Expenses + | 172 | 155 | 171 | 223 | 288 | 234 | 223 | 349 | 319 | 301 | 321 | 355 | 436 |
| Operating Profit | 27 | 32 | 78 | 42 | 34 | 26 | 24 | 32 | 15 | 2 | 25 | 17 | 52 |
| OPM % | 14% | 17% | 31% | 16% | 11% | 10% | 10% | 8% | 4.6% | 0.5% | 7% | 4.6% | 11% |
| Other Income + | 3 | 1 | 9 | 7 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 0 |
| Interest | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 7 | 9 |
| Depreciation | 4 | 4 | 5 | 5 | 6 | 7 | 7 | 12 | 13 | 14 | 14 | 17 | 17 |
| Profit before tax | 24 | 26 | 79 | 43 | 33 | 19 | 17 | 18 | -0 | -16 | 6 | -4 | 26 |
| Tax % | 32% | 36% | 33% | 28% | 32% | 18% | 28% | 11% | 88% | 20% | 18% | -90% | |
| Net Profit + | 16 | 17 | 53 | 31 | 23 | 16 | 12 | 16 | -1 | -19 | 5 | -0 | 29 |
| EPS in Rs | 21.88 | 22.75 | 72.37 | 37.26 | 27.54 | 19.16 | 15.24 | 19.81 | -1.17 | -23.25 | 5.94 | -0.55 | 35.79 |
| Dividend Payout % | 16% | 15% | 5% | 9% | 13% | 18% | 23% | 3% | -43% | -2% | 8% | -91% |
Financials of AksharChem (I)
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 64 | 78 | 133 | 230 | 249 | 257 | 271 | 272 | 270 | 251 | 256 | 254 | 282 |
| Borrowings + | 24 | 31 | 32 | 0 | 12 | 13 | 15 | 50 | 25 | 52 | 67 | 108 | 104 |
| Other Liabilities + | 51 | 39 | 47 | 61 | 47 | 45 | 62 | 76 | 62 | 70 | 85 | 82 | 106 |
| Total Liabilities | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 452 | 500 |
| Fixed Assets + | 55 | 56 | 65 | 86 | 126 | 128 | 229 | 231 | 225 | 235 | 232 | 287 | 289 |
| CWIP | 2 | 4 | 9 | 26 | 31 | 62 | 6 | 16 | 17 | 11 | 45 | 8 | 5 |
| Investments | 18 | 22 | 51 | 77 | 21 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 71 | 72 | 94 | 110 | 138 | 131 | 120 | 159 | 122 | 135 | 139 | 156 | 206 |
| Total Assets | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 452 | 500 |
Financials of AksharChem (I)
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 28 | 13 | 41 | 30 | -9 | 26 | 49 | 4 | 38 | -7 | 35 | 2 |
| Cash from Investing Activity + | -13 | -11 | -32 | -63 | -2 | -20 | -49 | -24 | -8 | -16 | -44 | -36 |
| Cash from Financing Activity + | -15 | -2 | -5 | 33 | 7 | -7 | 1 | 18 | -30 | 23 | 9 | 34 |
| Net Cash Flow | 0 | -0 | 3 | -0 | -4 | -0 | 1 | -1 | 0 | 0 | -0 | 0 |
| Free Cash Flow | 23 | 5 | 26 | -14 | -60 | -14 | -2 | -20 | 29 | -23 | -9 | -34 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 124% | 66% | 80% | 102% | 1% | 116% | 211% | 27% | 255% | -759% | 141% | 11% |
Financials of AksharChem (I)
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 44 | 20 | 38 | 43 | 42 | 42 | 51 | 39 | 57 | 43 | 61 |
| Inventory Days | 53 | 54 | 102 | 68 | 65 | 104 | 148 | 115 | 99 | 131 | 130 | 119 |
| Days Payable | 111 | 96 | 100 | 70 | 49 | 62 | 97 | 80 | 64 | 88 | 106 | 88 |
| Cash Conversion Cycle | -19 | 2 | 22 | 35 | 59 | 83 | 93 | 86 | 75 | 100 | 67 | 92 |
| Working Capital Days | 8 | 28 | 31 | 56 | 85 | 104 | 75 | 62 | 69 | 55 | 18 | -4 |
| ROCE % | 34% | 27% | 53% | 21% | 13% | 7% | 6% | 6% | 1% | -4% | 3% | 0% |
Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result
Revenue from operations (net) for the quarter ended 30/09/2026 is ₹40,336.95 lakhs, compared to ₹32,509.76 lakhs for the quarter ended 30/09/2025, reflecting a…
Q2 FY27 revenue from operations: ₹2,173 Mn, up 76% YoY from ₹1,235 Mn in Q2 FY26 (Page 11). Key investor presentation takeaways from Tatva Chintan's Q2 FY27 inv
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee